Earth Science Tech Shareholders Endorse Uplisting Strategy and Governance Overhaul

Earth Science Tech, Inc. (OTC: ETST), a diversified holding company focused on the health and wellness sector, announced the results of its first Annual Meeting of Stockholders, held virtually on Aug. 31, 2026. The company's shareholders voted in favor of key strategic initiatives, including a reverse stock split and the retirement of its Series B Preferred Stock, which are expected to position the company for a potential uplisting to a national securities exchange.

The reverse stock split, approved by shareholders, is valid for 12 months and will be implemented only if the board of directors deems it necessary to meet the minimum bid-price requirements for an uplisting. This move is a critical step for Earth Science Tech as it seeks to elevate its trading platform and attract a broader base of institutional investors. By potentially meeting the stricter listing standards of a national exchange, the company aims to enhance its visibility and credibility in the financial markets.

In addition, shareholders authorized the board's independent Special Committee to negotiate the retirement of the Series B Preferred Stock. This action would eliminate the company's dual-class, super-voting control structure, simplifying its governance and aligning it more closely with standard corporate practices. The retirement of the Series B shares is expected to be well-received by investors, as it reduces complexity and enhances shareholder rights.

Furthermore, shareholders approved a cash-only "Say-on-Pay" executive compensation structure with a three-year review cycle, reflecting a commitment to transparency and accountability in executive pay. All seven director nominees were re-elected, and Semple, Marchal & Cooper, LLP was ratified as the independent registered public accounting firm for the upcoming fiscal year.

Earth Science Tech has made the audio replay of the annual meeting available, which includes management guidance, additional details on the approved proposals, and a shareholder question-and-answer session. This transparency underscores the company's dedication to keeping its investors informed and engaged.

The approval of these measures is a significant milestone for Earth Science Tech, which operates as a vertically integrated healthcare platform combining compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The company's strategic focus on seamless patient care, from consultation to fulfillment, is supported by its specialized subsidiaries.

For more information about Earth Science Tech and its latest updates, interested parties can visit the company's newsroom at https://ibn.fm/ETST.

The full press release regarding the shareholder meeting can be accessed at https://ibn.fm/KCU5p.

Earth Science Tech's progress and strategic decisions are closely watched by investors and industry observers, as the company continues to carve out its niche in the health and wellness sector. With these shareholder approvals, Earth Science Tech is poised to take significant steps toward achieving its long-term growth objectives and enhancing shareholder value.